SAN FRANCISCO, CA, ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised $13 million in seed financing.
Continue Reading
Sign up for FREE to read the full article and access 128K+ alternative investment headlines.